Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Tuberculosis

  Free Subscription


Articles published in Eur J Clin Microbiol Infect Dis

Retrieve available abstracts of 23 articles:
HTML format



Single Articles


    May 2025
  1. MALHOTRA AG, Lokhande L, Pakhare A, Soni P, et al
    Diagnostic yield of Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB assays on non-pulmonary samples from suspected cases of extra-pulmonary tuberculosis (EPTB).
    Eur J Clin Microbiol Infect Dis. 2025 May 31. doi: 10.1007/s10096-025-05177.
    PubMed     Abstract available


  2. FEI ZT, Zhou DP, Huang W, Liu P, et al
    Clinical characteristics and outcomes of tuberculosis and non-tuberculous mycobacteria infections: a population-based study of concurrent and sequential infections.
    Eur J Clin Microbiol Infect Dis. 2025 May 9. doi: 10.1007/s10096-025-05151.
    PubMed     Abstract available


    April 2025
  3. DING W, Shen L, Li R, Yang X, et al
    Treatment of pre-extensively drug-resistant tuberculosis in a 4-month-old infant using a regimen of bedaquiline, delamanid, and contezolid.
    Eur J Clin Microbiol Infect Dis. 2025 Apr 9. doi: 10.1007/s10096-025-05128.
    PubMed     Abstract available


    March 2025
  4. QUAN DH, Wang T, Martinez E, Kim HY, et al
    Beta-lactam combination treatment overcomes rifampicin resistance in Mycobacterium tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2025 Mar 6. doi: 10.1007/s10096-025-05062.
    PubMed     Abstract available


    January 2025
  5. WANG MQ, Zheng YF, Hu YQ, Huang JX, et al
    Diagnostic accuracy of Xpert MTB/RIF Ultra for detecting pulmonary tuberculosis and rifampicin resistance: a systematic review and meta-analysis.
    Eur J Clin Microbiol Infect Dis. 2025 Jan 4. doi: 10.1007/s10096-024-05032.
    PubMed     Abstract available


    August 2024
  6. TURAN H, Gunak F, Yasaci Z, Ethemoglu G, et al
    Impact of the COVID-19 pandemic and migration on tuberculosis notifications: a retrospective analysis with 5-year data from three centers.
    Eur J Clin Microbiol Infect Dis. 2024 Aug 7. doi: 10.1007/s10096-024-04918.
    PubMed     Abstract available


  7. ZHANG W, Xu J, Zhang L, Ni T, et al
    The value of histopathologic examination and Xpert (MTB/RIF) assay in diagnosis of cervical lymph node tuberculosis after coarse needle biopsy guided by CEUS: a retrospective analysis of 612 cases.
    Eur J Clin Microbiol Infect Dis. 2024 Aug 1. doi: 10.1007/s10096-024-04913.
    PubMed     Abstract available


    July 2024
  8. FERRER J, Gimenez E, Carretero D, Clari MA, et al
    Abbott realtime MTB assay for detecting Mycobacterium tuberculosis complex in respiratory specimens: a cost-benefit analysis.
    Eur J Clin Microbiol Infect Dis. 2024 Jul 3. doi: 10.1007/s10096-024-04880.
    PubMed     Abstract available


    June 2024
  9. WEN R, Xiao J, Ding N, Zhong Y, et al
    Suitability of reduced dose glucocorticoids therapy regimen for antibody-associated vasculitis patients with TB: a retrospective study.
    Eur J Clin Microbiol Infect Dis. 2024;43:1061-1072.
    PubMed     Abstract available


    April 2024
  10. CHEN Y, Liu J, Zhang Q, Chen H, et al
    Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
    Eur J Clin Microbiol Infect Dis. 2024;43:747-765.
    PubMed     Abstract available


    February 2024
  11. CAO X, Guo T, Xin H, Du J, et al
    Cost-effectiveness of latent tuberculosis infection testing and treatment with 6-week regimen among key population in rural communities in China: a decision analysis study.
    Eur J Clin Microbiol Infect Dis. 2024 Feb 22. doi: 10.1007/s10096-024-04777.
    PubMed     Abstract available


    January 2024
  12. ACHEAMPONG I, Minadzi D, Laing EF, Frimpong M, et al
    Differences in PPD- and mitogen-induced T-cell activation marker expression characterize immunopathology in acute tuberculosis patients.
    Eur J Clin Microbiol Infect Dis. 2024 Jan 3. doi: 10.1007/s10096-023-04741.
    PubMed     Abstract available


    December 2023
  13. SUN H, Ma Z, Ai F, Han B, et al
    Insidious transmission of Mycobacterium tuberculosis in Ordos, China: a molecular epidemiology study.
    Eur J Clin Microbiol Infect Dis. 2023 Dec 6. doi: 10.1007/s10096-023-04730.
    PubMed     Abstract available


  14. QUAN Z, Li M, Chen Y, Liang J, et al
    Performance evaluation of core genome multilocus sequence typing for genotyping of Mycobacterium tuberculosis strains in China: based on multicenter, population-based collection.
    Eur J Clin Microbiol Infect Dis. 2023 Dec 2. doi: 10.1007/s10096-023-04720.
    PubMed     Abstract available


    November 2023
  15. OU X, Song Z, Zhao B, Pei S, et al
    Diagnostic efficacy of an optimized nucleotide MALDI-TOF-MS assay for anti-tuberculosis drug resistance detection.
    Eur J Clin Microbiol Infect Dis. 2023 Nov 18. doi: 10.1007/s10096-023-04700.
    PubMed     Abstract available


  16. PINHATA JMW, Ferrazoli L, Mendes FF, Goncalves MG, et al
    A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country.
    Eur J Clin Microbiol Infect Dis. 2023 Nov 9. doi: 10.1007/s10096-023-04693.
    PubMed     Abstract available


    September 2023
  17. NAGDEV PK, Agnivesh PK, Roy A, Sau S, et al
    Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection.
    Eur J Clin Microbiol Infect Dis. 2023 Sep 23. doi: 10.1007/s10096-023-04663.
    PubMed     Abstract available


    July 2023
  18. MEI ZX, Han JF, Yu HW, Zhang Y, et al
    Detection of serum Aspergillus-specific IgM and IgG antibody levels for the diagnosis of chronic pulmonary aspergillosis developed in patients with tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2023 Jul 16. doi: 10.1007/s10096-023-04637.
    PubMed     Abstract available


    June 2023
  19. TANOGLU A, Erdem H, Friedland JS, Ankarali H, et al
    Clinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI study.
    Eur J Clin Microbiol Infect Dis. 2023 Jun 15. doi: 10.1007/s10096-023-04630.
    PubMed     Abstract available


    May 2023
  20. LIU Y, Ren W, Xue Z, Miao Y, et al
    Real-time recombinase-aided amplification assay for rapid amplification of the IS1081 gene of Mycobacterium tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2023 May 31. doi: 10.1007/s10096-023-04626.
    PubMed     Abstract available


  21. CASTRO-LIMA VAC, Santos APT, Musqueira PT, Maluf NZ, et al
    Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay.
    Eur J Clin Microbiol Infect Dis. 2023 May 1. doi: 10.1007/s10096-023-04613.
    PubMed     Abstract available


    April 2023
  22. YEZLI S, Yassin Y, Mushi A, Maashi F, et al
    Undiagnosed and missed active pulmonary tuberculosis during mass gatherings: a prospective cross-sectional study from the Hajj pilgrimage.
    Eur J Clin Microbiol Infect Dis. 2023.
    PubMed     Abstract available


    February 2023
  23. YANG L, Xiang F, Wang D, Guo Q, et al
    The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients.
    Eur J Clin Microbiol Infect Dis. 2023.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.